T
WST icon

TOBAM’s West Pharmaceutical WST Stock Holding History

TOBAM’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Sell
6,445
-8,629
-57% -$2.64M 0.56% 59
2026
Q1 		$3.78M Sell
15,074
-921
-6% -$229K 0.98% 38
2025
Q4 		$4.4M Sell
15,995
-343
-2% -$93.8K 1.08% 34
2025
Q3 		$4.29M Sell
16,338
-3,857
-19% -$937K 1.55% 23
2025
Q2 		$4.42M Buy
20,195
+6,040
+43% +$1.29M 1.72% 19
2025
Q1 		$3.17M Buy
14,155
+9,642
+214% +$2.66M 1.35% 23
2024
Q4 		$1.48M Buy
4,513
+813
+22% +$256K 0.45% 68
2024
Q3 		$1.11M Buy
3,700
+2,423
+190% +$742K 0.2% 87
2024
Q2 		$421K Sell
1,277
-9,429
-88% -$3.33M 0.07% 121
2024
Q1 		$4.24M Buy
10,706
+10,295
+2,505% +$3.81M 0.38% 57
2023
Q4 		$145K Sell
411
-166
-29% -$58.7K 0.01% 256
2023
Q3 		$216K Buy
577
+86
+18% +$33.3K 0.02% 210
2023
Q2 		$188K Hold
491
– – 0.01% 252
2023
Q1 		$170K Buy
491
+97
+25% +$28.3K 0.01% 246
2022
Q4 		$93K Hold
394
– – 0.01% 310
2022
Q3 		$97K Hold
394
– – 0.01% 285
2022
Q2 		$119K Sell
394
-87
-18% -$28.3K 0.01% 292
2022
Q1 		$198K Buy
481
+230
+92% +$90K 0.01% 234
2021
Q4 		$118K Hold
251
– – 0.01% 247
2021
Q3 		$107K Hold
251
– – ﹤0.01% 257
2021
Q2 		$90K Hold
251
– – ﹤0.01% 274
2021
Q1 		$71K Hold
251
– – ﹤0.01% 289
2020
Q4 		$71K Hold
251
– – ﹤0.01% 275
2020
Q3 		$69K Buy
+251
New +$66.4K ﹤0.01% 261

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

TOBAM's WST Position: Q2 2026 in Review

TOBAM reduced its West Pharmaceutical (WST) stake by 57% in Q2 2026, selling an estimated $2.64M and leaving 6,445 shares worth $2.31M. The position accounts for 0.56% of the portfolio, ranked #59.

TOBAM first reported a position in WST in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.42M in Q2 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • TOBAM held 6,445 shares of West Pharmaceutical worth $2.31M as of Q2 2026.
  • TOBAM sold 8,629 West Pharmaceutical shares in Q2 2026, an estimated $2.64M.
  • West Pharmaceutical made up 0.56% of TOBAM's portfolio in Q2 2026, its #59 holding.
  • TOBAM first reported a position in West Pharmaceutical in Q3 2020 and has held it in 24 quarters since.
  • TOBAM's West Pharmaceutical position peaked at $4.42M in Q2 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.